Cannabidiol Research Update – Dr. W. McInytre Burnham
The importance of developing new drug therapies for drug-resistant epilepsy is coming to the forefront. GW Pharmaceuticals, a British drug company, has just completed an important clinical trial examining the safety and effectiveness of a drug based on the marijuana extract, cannabidiol, in children with Dravet Syndrome. Among other developmental disabilities, children with Dravet Syndrome experience…